On May 8, 2020, we premiered a virtual meeting of the Commission to better understand the ongoing response to novel coronavirus 2019, national readiness to address possible large-scale spread of the disease in the United States and throughout the world, and implications for improving preparedness for the next biological threat.
More information about this meeting, including a full agenda, is available <a href='https://biodefensecommission.org/events/covid-19-forewarned-but-not-forearmed-2/'>here.</a>

On May 8, 2020, we premiered a virtual meeting of the Commission to better understand the ongoing response to novel coronavirus 2019, national readiness to address possible large-scale spread of the disease in the United States and throughout the world, and implications for improving preparedness for the next biological threat. More information about this meeting, including a full agenda, is available here.

On May 8, 2020, we premiered a&nbsp;virtual meeting of the Commission to better understand the ongoing response to novel coronavirus 2019, national readiness to address possible large-scale spread of the disease in the United States and throughout the world, and implications for improving preparedness for the next biological threat.
More information about this meeting, including a full agenda, is available <a href="https://biodefensecommission.org/events/covid-19-forewarned-but-not-forearmed-2/" rel="noopener noreferrer">here.</a>

COVID-19: Forewarned, But Not Forearmed

The Bipartisan Commission on Biodefense is a privately funded entity established in 2014 to provide for a comprehensive assessment of the state of U.S. biodefense efforts and to issue recommendations that will foster change.

From 2014-2015, the Commission convened four public meetings in Washington, DC on biological threat awareness, prevention and protection, surveillance and detection, and response and recovery. Current and former Members of Congress, former Administration officials, state and local representatives, thought leaders, and other experts provided their perspectives on current biodefense efforts, including strengths, weaknesses, and opportunities. While much good work has been achieved toward biodefense, these meetings have revealed systemic challenges in the enterprise designed to protect Americans from biological events.

The Commission continues to advocate for uptake of these recommendations at the highest levels of American government, through additional meetings, reports, and other activities, and is the only such body of bipartisan, former high-level policymakers to do so.

Science

Education

Government

Life Sciences

The Bipartisan Commission on Biodefense is a privately funded entity established in 2014 to provide for a comprehensive assessment of the state of U.S. biodefense efforts and to issue recommendations that will foster change. From 2014-2015, the Commission convened four public meetings in Washington, DC on biological threat awareness, prevention and protection, surveillance and detection, and response and recovery. Current and former Members of Congress, former Administration officials, state and local representatives, thought leaders, and other experts provided their perspectives on current biodefense efforts, including strengths, weaknesses, and opportunities. While much good work has been achieved toward biodefense, these meetings have revealed systemic challenges in the enterprise designed to protect Americans from biological events. The Commission continues to advocate for uptake of these recommendations at the highest levels of American government, through additional meetings, reports, and other activities, and is the only such body of bipartisan, former high-level policymakers to do so.

Share COVID-19: Forewarned, But Not Forearmed

Sign up to save your podcasts

COVID-19: Forewarned, But Not Forearmed

COVID-19: Forewarned, But Not Forearmed